1. The Potential of panHER Inhibition in Cancer
   Xiaochun Wang et al, 2015, Front. Oncol. CrossRef
2. Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries
   Daniel Sun et al, 2017, J. Exp. Med. CrossRef
3. Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation
   Brian F. Kiesel et al, 2016, Cancer Chemother Pharmacol CrossRef
4. Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
   Yunbao Pan et al, 2013, PLoS ONE CrossRef
5. Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
   Khalid Abubaker et al, 2014, Front. Oncol. CrossRef
6. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion
   Cuiqi Zhou et al, 2015, J. Clin. Invest. CrossRef
7. The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation
   WEI ZHOU et al, 2016 CrossRef
8. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
   Jaemoo Chun et al, 2015, Cancer Letters CrossRef
9. Immune evasion in cancer: Mechanistic basis and therapeutic strategies.
   Dass S Vinay et al, 2015, Semin. Cancer Biol. CrossRef
10. 2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway
    Matthew G. LaPorte et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef
11. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
    Xiaojian Liu et al, 2014, Oncol Rep CrossRef
12. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis
    Martin E. Rottenberg et al, 2014, Seminars in Immunology CrossRef
13. Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
    Sung-Moo Kim et al, 2014, Cancer Letters CrossRef
14. Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.
    Tao Xu et al, 2015, Oncol. Rep. CrossRef
15. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein
    Shanshan Li et al, 2016, European Journal of Medicinal Chemistry CrossRef
16. MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells
    J-Y Yoo et al, 2017, Oncogene CrossRef
17. The transcription factor Gbx2 induces expression of Kruppel-like factor 4 to maintain and induce naïve pluripotency of embryonic stem cells
    Manman Wang et al, 2017, J. Biol. Chem. CrossRef
18. Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway
    Gang Xu et al, 2017, BioMed Research International CrossRef
19. Identification of new shikonin derivatives as STAT3 inhibitors
    Han-Yue Qiu et al, 2017, Biochemical Pharmacology CrossRef
20. Withaferin A Inhibits STAT3 and Induces Tumor Cell Death in Neuroblastoma and Multiple Myeloma
    Lisette P. Yco et al, 2014, Biochemistry Insights CrossRef
21. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
    Ommoleila Molavi et al, 2017, Pharmaceutical Biology CrossRef
22. STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
    Melanie Spitzner et al, 2014, Cancers CrossRef
23. STAT3 in Cancer—Friend or Foe?
    Hai-Feng Zhang et al, 2014, Cancers CrossRef
24. Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling
    Youn Choi et al, 2017, Marine Drugs CrossRef
25. Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase
    Seung Baek et al, 2017, Molecules CrossRef
26. Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma
    Jia-Lin Yang et al, 2017, IJMS CrossRef
27. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
    Tzu-Ting Huang et al, 2017, Int J Mol Sci CrossRef
28. Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells.
    Wei Li et al, 2017, Acta Biochim Biophys Sin (Shanghai) CrossRef
29. Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens
    Kazim Sahin et al, 2018, J Cancer Prev CrossRef
30. Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M
    Srinath C. Sampath et al, 2018, Nat Commun CrossRef
31. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
    Jenny Beebe et al, 2018, Pharmacology & Therapeutics CrossRef
32. STAT3 isoforms: Alternative fates in cancer?
    Petra Aigner et al, 2018, Cytokine CrossRef
33. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells
    Shuwei Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
34. Cross Talk between the TM4SF5/Focal Adhesion Kinase and the Interleukin-6/STAT3 Pathways Promotes Immune Escape of Human Liver Cancer Cells
    Jihye Ryu et al, 2014, Mol. Cell. Biol. CrossRef
35. The multifaceted STAT3: how a transcription factor regulates Ca2+ signaling via a degradative pathway
    Jan B. Parys, 2018, Cell Calcium CrossRef
36. SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone
    Martín Garrido-Rodríguez et al, 2018, Journal of Proteomics CrossRef
37. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
    Ga Bin Park et al, 2019, Neoplasia CrossRef
38. STAT3 Inhibitors as Sensitizing Agents for Cancer Chemotherapy
    Yang Yang et al, 2019 CrossRef
39. STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer
    Joseph D Fleming et al, 2015, Epigenetics & Chromatin CrossRef
40. STAT3beta, a distinct isoform from STAT3
    Hui-Xiang Zhang et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
41. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
    Shaoyong Lu et al, 2019, J. Med. Chem. CrossRef
42. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
    S Carbajo-Pescador et al, 2013, Br J Cancer CrossRef
43. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors
    Guiping Cai et al, 2019, European Journal of Medicinal Chemistry CrossRef
44. STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
    Ji-Sun Lee et al, 2015, Nat Commun CrossRef
45. IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis
    Rei Nakamura et al, 2015, Nat Commun CrossRef
46. Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
    S-C Lee et al, 2016, Oncogene CrossRef
47. At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells
    Uri Rozovski et al, 2016, J.I. CrossRef
48. Atiprimod induce apoptosis in pituitary adenoma: Endoplasmic reticulum stress and autophagy pathways
    Ajda Coker‐Gurkan et al, 2019, J Cell Biochem CrossRef
49. Alternative ways of modulating JAK-STAT pathway
    Olga A. Timofeeva et al, 2012, JAK-STAT CrossRef
50. STAT3 Pathway Is Activated in ALK-positive Large B-cell Lymphoma Carrying SQSTM1-ALK Rearrangement and Provides a Possible Therapeutic Target
    Emanuele S.G. d’Amore et al, 2013, The American Journal of Surgical Pathology CrossRef
51. Virus induced inflammation and cancer development
    Scott A. Read et al, 2014, Cancer Letters CrossRef
52. Role of Stat3 Activation in Cell-Cell Interaction between B-Cell Lymphoma and Macrophages : The in vitro Study
    Bing Bai et al, 2013, J Clin Exp Hematopathol CrossRef
53. Evaluation of the Prognostic Role of pSTAT3 Expression in Temporal Bone Squamous Cell Carcinoma
    Gino Marioni et al, 2013, Otology & Neurotology CrossRef
54. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
    Walhan Alshaer et al, 2019, IJMS CrossRef
55. Screening of Stat3 inhibitory effects of Korean herbal medicines in the A549 human lung cancer cell line
    Jong-Shik Park et al, 2014, Integrative Medicine Research CrossRef
56. AZD1480 Can Inhibit the Biological Behavior of Ovarian Cancer SKOV3 Cells in vitro
    Zhao-Ling Sun et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef
57. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts
    Chi Man Tsang et al, 2013, BMC Cancer CrossRef
58. Toward a new STATe: The role of STATs in mitochondrial function
    Jeremy A. Meier et al, 2014, Seminars in Immunology CrossRef
59. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Koji Taniguchi et al, 2014, Semin Immunol CrossRef
60. Inhibition of STAT3 activation by KT-18618 via the disruption of the interaction between JAK3 and STAT3
    Dae-Seop Shin et al, 2014, Biochemical Pharmacology CrossRef
61. Microenvironmental Clues for Glioma Immunotherapy
    Michael Platten et al, 2014, Curr Neurol Neurosci Rep CrossRef
62. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
    Khalid Abubaker et al, 2014, BMC Cancer CrossRef
63. Improved chemosensitivity in cervical cancer to cisplatin: Synergistic activity of mahanine through STAT3 inhibition
    Ranjita Das et al, 2014, Cancer Letters CrossRef
64. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3
    Saet-Byul Oh et al, 2014, Cancer Letters CrossRef
65. Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
    Ho-June Lee et al, 2014, Cancer Cell CrossRef
66. Novel Thiosemicarbazones Regulate the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway: Inhibition of Constitutive and Interleukin 6–Induced Activation by Iron Depletion
    Goldie Y. L. Lui et al, 2015, Mol Pharmacol CrossRef
67. Astaxanthin Inhibits JAK/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer
    J. Kowshik et al, 2014, PLoS ONE CrossRef
68. 14-3-3ζ Regulates Immune Response through Stat3 Signaling in Oral Squamous Cell Carcinoma
    Xinguang Han et al, 2015 CrossRef
69. Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network
    Guanyi Huang et al, 2015, Cell. Mol. Life Sci. CrossRef
70. The role of STAT3 in tumor-mediated immune suppression
    Sherise D. Ferguson et al, 2015, J Neurooncol CrossRef
71. Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression
    Yun Hong et al, 2015, Biochemical and Biophysical Research Communications CrossRef
72. Targeting protein–protein interactions (PPIs) of transcription factors: Challenges of intrinsically disordered proteins (IDPs) and regions (IDRs)
    Susan Sammak et al, 2015, Progress in Biophysics and Molecular Biology CrossRef
73. Prognostic Significance of Serine-Phosphorylated STAT3 Expression in pT1-T2 Oral Tongue Carcinoma
    Elena Fasanaro et al, 2015, Clin Exp Otorhinolaryngol CrossRef
74. Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis
    Yi Qin et al, 2016, Tumor Biol. CrossRef
75. Understanding STAT3 signaling in cardiac ischemia
    K. E. O’Sullivan et al, 2016, Basic Res Cardiol CrossRef
76. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
    Silke Reinartz et al, 2016, Genome Biol CrossRef
77. Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors
    Matthew G. LaPorte et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
78. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer
    Hiroe Nakamura et al, 2016, BMC Cancer CrossRef
79. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype
    Fanping Kong et al, 2017, PLoS Pathog CrossRef
80. Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma
    Amir H. Soleimani et al, 2017, Drug Deliv. and Transl. Res. CrossRef
81. Taming the immune system through transfusion in oncology patients
    Seyed Mohammad Amin Kormi et al, 2017, Transfusion and Apheresis Science CrossRef
82. miR-124 and Parkinson's disease: A biomarker with therapeutic potential.
    Efthalia Angelopoulou et al, 2019, Pharmacol Res CrossRef
83. Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo
    Zhe Liu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
84. Development of an HPLC-UV Method for Quantification of Stattic
    Soheil Sedaghat et al, 2019, CPA CrossRef
85. Ferulic acid maintains the self-renewal capacity of embryo stem cells and adipose-derived mesenchymal stem cells in high fat diet-induced obese mice
    Jinkyung Cho et al, 2019, The Journal of Nutritional Biochemistry CrossRef
86. Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad
    Ju-Hee Kang et al, 2019, Lab Anim Res CrossRef
87. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Sevda Jafari et al, 2020, Daru CrossRef
88. Convallatoxin Promotes Apoptosis and Inhibits Proliferation and Angiogenesis through Crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) Signaling Pathways in Colorectal Cancer
    Zhi Hong Zhang et al, 2020, Phytomedicine CrossRef
89. Arylidenes of Quinolin-2-one scaffold as Erlotinib analogues with activities against leukemia through inhibition of EGFR TK/ STAT-3 pathways
    Mohammed A.I. Elbastawesy et al, 2020, Bioorganic Chemistry CrossRef
90. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation
    Hongda Ding et al, 2020, Cell Mol Biol Lett CrossRef
91. Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
    Emily Chan et al, 0 CrossRef
92. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma
    Jia-Jie Chen et al, 2017, Oncotarget CrossRef
93. Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
    Xiaochun Wang et al, 2016, Oncotarget CrossRef
94. Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors
    Steffanie L. Furtek et al, 2016, Oncotarget CrossRef
95. The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
    Xiaochun Wang et al, 2020, Oncotarget CrossRef
96. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle
    Francesca Pretto et al, 2015, Oncotarget CrossRef
97. Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3
    Xin Qi et al, 2020, Molecules CrossRef
98. BP-1-102 and silencing of Fascin-1 by RNA interference inhibits the proliferation of mouse pituitary adenoma AtT20 cells via the signal transducer and activator of transcription 3/fascin-1 pathway
    GuoDong Qian et al, 2020, International Journal of Neuroscience CrossRef
99. STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection
    Miguel S. Gonzalez-Mancera et al, 2020, Respiratory Medicine Case Reports CrossRef
100. Down‐regulation of microRNA‐34c‐5p alleviates neuropathic pain via the SIRT1/STAT3 signaling pathway in rat models of chronic constriction injury of sciatic nerve
     Yanshuai Mo et al, 2020, J. Neurochem. CrossRef
101. Inhibition of JAK2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells
     Bo‑Im Kim et al, 2019, Int J Oncol CrossRef
102. Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines
     Xiaochun Wang et al, 2018, Int J Oncol CrossRef
103. Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
     Yuguang Yang et al, 2018, Oncol Lett CrossRef
104. A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception
     Kaviarasan Lakshmanan et al, 2020, CEI CrossRef
105. An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target
     Sung-Jun Hong et al, 2020, Biomedicines CrossRef
106. Natural Salicylates and Their Roles in Human Health
     Fatema Yeasmin et al, 2020, IJMS CrossRef
107. Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors
     Veronika Mancikova et al, 2017, Clin Cancer Res CrossRef
108. Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
     Uri Rozovski et al, 2015, Mol Cancer Res CrossRef
109. Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling.
     Yufei Fu et al, 2021, Onco Targets Ther CrossRef
110. Costunolide, a Sesquiterpene Lactone, Suppresses Skin Cancer via Induction of Apoptosis and Blockage of Cell Proliferation
     Sung Ho Lee et al, 2021, IJMS CrossRef
111. Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
     Keisuke Taniguchi et al, 2021, Sci Rep CrossRef
112. Albendazole Exhibits Anti-Neoplastic Actions against Gastric Cancer Cells by Affecting STAT3 and STAT5 Activation by Pleiotropic Mechanism(s)
     Min Hee Yang et al, 2021, Biomedicines CrossRef
113. Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer
     Yuhao Ren et al, 2021, J. Med. Chem. CrossRef
114. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.
     Jinyun Dong et al, 2021, J Med Chem CrossRef
115. Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
     Min Ye et al, 2021, Front. Pharmacol. CrossRef
116. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach
     Ali N. Chamseddine et al, 2021, Pharmacology & Therapeutics CrossRef
117. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease
     Jing Pan et al, 2021, Life Sciences CrossRef
118. Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer
     Austin R. Dosch et al, 2021, Mol Cancer Ther CrossRef
119. Redox regulation of DUBs and its therapeutic implications in cancer
     Apoorvi Tyagi et al, 2021, Redox Biology CrossRef
120. TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis
     Gaowu Hu et al, 2019, oncol res CrossRef
121. Synthesis and Antiproliferative Activity of Ester Derivatives of Mogrol through JAK2/STAT3 Pathway
     Na Li et al, 2022, Chemistry & Biodiversity CrossRef
122. Long Non-coding RNA H19 Deteriorates Hypoxic-Ischemic Brain Damage by Interacting with MicroRNA-140-5p and STAT3
     Qian Lu et al, 2022, Nanoscale Res Lett CrossRef
123. Anticancer activity of IRAK ‐4 inhibitors against canine lymphoid malignancies
     Jun‐Hyeong Park et al, 2022, Vet Comparative Oncology CrossRef
124. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.
     Gautam Sethi, 0 CrossRef
125. Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment
     Peng He et al, 2022, J. Med. Chem. CrossRef
126. Downregulation of miR-125a-5p Leads to STAT3 Increased Expression in Breast Cancer Patients
     Negar Shafagh Shishavan et al, 2022, MIRNA CrossRef
127. Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy.
     Sevda Jafari et al, 2023, Bioimpacts CrossRef
128. Targeting Signal Transducer and Activator of Transcripion (STAT) 3 with Small Molecules
     Andrew E. Shouksmith et al, 2018 CrossRef
129. Advances in the role of STAT3 in macrophage polarization
     Tingting Xia et al, 2023, Front. Immunol. CrossRef
130. Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes
     Tariq Alqahtani et al, 2023, Cancers CrossRef
131. In Silico Prediction Model of STAT3 Inhibition and in Vivo Antitumor Activity of Cucurbitacin IIb and Kinoin a from Ibervillea Sonorae
     Heriberto Torres-Moreno et al, 2022, SSRN Journal CrossRef
132. A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson’s Disease
     Adam Szelągowski et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
133. Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
     Namthip Kaewbandit et al, 2023, Sci Rep CrossRef
134. Evaluation of  premetastatic changes in lymph nodes(pN0) of oral tongue tumour: A prospective observational Study
     Rajalakshmi Geetha et al, 2023, F1000Res CrossRef
135. Antimetastatic activity of seongsanamide B in γ-irradiated human lung cancer
     Ga-Hee Ryoo et al, 2023, Heliyon CrossRef
136. Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
     Huma Rafiq et al, 2023, Sci Rep CrossRef
137. ZNF70 regulates IL-1β secretion of macrophages to promote the proliferation of HCT116 cells via activation of NLRP3 inflammasome and STAT3 pathway in colitis-associated colorectal cancer
     Zhihong Zhang et al, 2023, Cellular Signalling CrossRef
138. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
     Sara Molenda et al, 2023, Cancers CrossRef
139. Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update
     Suryaa Manoharan et al, 2023, Life Sciences CrossRef
140. miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis
     Cong-Gai Huang et al, 2023, Clin Med Insights Oncol CrossRef
141. Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells
     Heba Effat et al, 2024, Sci Rep CrossRef
142. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation
     Tiancheng Wang et al, 2024, CAD CrossRef
143. Banxia Xiexin Decoction inhibits colitis-associated colorectal cancer development by modulating STAT3 signaling and gut microbiota
     Yinzi Yue et al, 2024, Chinese Herbal Medicines CrossRef
144. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma
     Sachindra Kumar et al, 2024, Translational Oncology CrossRef
145. Research progress of multi-target HDAC inhibitors blocking the BRD4-LIFR-JAK1-STAT3 signaling pathway in the treatment of cancer
     Shuting Jia et al, 2024, Bioorganic & Medicinal Chemistry CrossRef
146. LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling
     Yuet Ping Kwan et al, 2021, Cancers CrossRef
147. Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy
     Indy Bui et al, 2024, Crit Rev Oncog CrossRef
148. Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential
     Sho Sato et al, 2025, J Gynecol Oncol CrossRef
149. In-Silico Assessment of Novel Peptidomimetics Inhibitor Targeting STAT3 and STAT4 N-Terminal Domain Dimerization: A Comprehensive Study Using Molecular Docking, Molecular Dynamics Simulation, and Binding Free Energy Analysis.
     Megha Shree et al, 2024, Biochemical and Biophysical Research Communications CrossRef
150. Targeting STAT3-Mediated Autophagy with Small Molecules in Cancer Treatment - A Comprehensive Review
     S.M. Asadul Karim Azad et al, 2024, Clinical Traditional Medicine and Pharmacology CrossRef
151. A strategic review of STAT3 signaling inhibition by phytochemicals for cancer prevention and treatment: Advances and insights
     Suryaa Manoharan et al, 2024, Fitoterapia CrossRef
152. STAG2 promotes naive-primed transition via activating Lin28a transcription in mouse embryonic stem cells
     Bo Chen et al, 2024, Journal of Biological Chemistry CrossRef
153. Effect of Soy Isoflavone on Prostate Cancer Cell Apoptosis Through Inhibition of STAT3, ERK, and AKT
     Yoon-Jin Lee et al, 2024, CIMB CrossRef
154. pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
     Piotr Bialas et al, 2024, The Prostate CrossRef